1. Home
  2. RANI vs CRT Comparison

RANI vs CRT Comparison

Compare RANI & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • CRT
  • Stock Information
  • Founded
  • RANI 2012
  • CRT 1991
  • Country
  • RANI United States
  • CRT United States
  • Employees
  • RANI 140
  • CRT N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • CRT Oil & Gas Production
  • Sector
  • RANI Health Care
  • CRT Energy
  • Exchange
  • RANI Nasdaq
  • CRT Nasdaq
  • Market Cap
  • RANI 55.3M
  • CRT 60.9M
  • IPO Year
  • RANI 2021
  • CRT 1992
  • Fundamental
  • Price
  • RANI $1.66
  • CRT $10.66
  • Analyst Decision
  • RANI Strong Buy
  • CRT
  • Analyst Count
  • RANI 6
  • CRT 0
  • Target Price
  • RANI $11.33
  • CRT N/A
  • AVG Volume (30 Days)
  • RANI 2.3M
  • CRT 27.0K
  • Earning Date
  • RANI 03-19-2025
  • CRT 01-01-0001
  • Dividend Yield
  • RANI N/A
  • CRT 8.01%
  • EPS Growth
  • RANI N/A
  • CRT N/A
  • EPS
  • RANI N/A
  • CRT 1.13
  • Revenue
  • RANI N/A
  • CRT $7,711,133.00
  • Revenue This Year
  • RANI N/A
  • CRT N/A
  • Revenue Next Year
  • RANI N/A
  • CRT N/A
  • P/E Ratio
  • RANI N/A
  • CRT $9.73
  • Revenue Growth
  • RANI N/A
  • CRT N/A
  • 52 Week Low
  • RANI $1.24
  • CRT $8.88
  • 52 Week High
  • RANI $8.75
  • CRT $17.72
  • Technical
  • Relative Strength Index (RSI)
  • RANI 54.80
  • CRT 50.85
  • Support Level
  • RANI $1.59
  • CRT $10.23
  • Resistance Level
  • RANI $1.90
  • CRT $11.36
  • Average True Range (ATR)
  • RANI 0.15
  • CRT 0.34
  • MACD
  • RANI 0.03
  • CRT 0.01
  • Stochastic Oscillator
  • RANI 56.36
  • CRT 38.05

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

About CRT Cross Timbers Royalty Trust

Cross Timbers Royalty Trust is a United States based trust. Its principal asset is the net profits interests. The net profits interests are derived from producing royalty, overriding royalty interests, and working interests properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.

Share on Social Networks: